Keywords: cethromycin, effective, against, cap, abecb, nasdaq-listed, early-stage

Cethromycin effective against CAP and ABECB

Article | 09 October 2006

Nasdaq-listed early-stage US drug developer, Advanced Life Sciences Holdings, presented promising efficacy data at the 46th Interscience Conference on Antimicrobial ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Nystatin

Levaquin

Levofloxacin

Go to drug listing